Mutation in blood coagulation factor V associated with resistance to activated protein C.
about
Hereditary thrombophiliaThe relationship between FV Leiden and pulmonary embolismA comprehensive review of genetic association studiesOnce versus twice daily low molecular weight heparin for the initial treatment of venous thromboembolismThrombophilia testing for prevention of recurrent venous thromboembolismThrombophilia testing for prevention of recurrent venous thromboembolismOnce versus twice daily low molecular weight heparin for the initial treatment of venous thromboembolismIncreased tissue factor-initiated prothrombin activation as a result of the Arg506 --> Gln mutation in factor VLEIDENA targeted point mutation in thrombomodulin generates viable mice with a prethrombotic stateNeutrophil extracellular traps promote deep vein thrombosis in miceModulation of prothrombinase assembly and activity by phosphatidylethanolamineBehçet's disease: from Hippocrates to the third millenniumThrombophilia and pregnancyMining literature for a comprehensive pathway analysis: a case study for retrieval of homocysteine related genes for genetic and epigenetic studiesMedical case reports in the age of genomic medicineInflammatory bowel disease and thrombosisActivated protein C anticoagulant system dysfunction and thrombophilia in AsiaProtein C anticoagulant and cytoprotective pathwaysThe role of thrombophilia in pregnancyThe 2.8 A crystal structure of Gla-domainless activated protein CThrombophilia in East Asian countries: are there any genetic differences in these countries?Progress in research into the genes associated with venous thromboembolismClinical manifestations in thrombotic children with factor V Leiden mutationProthrombotic gene polymorphisms and atherothrombotic cerebral infarctionThe discovery of activated protein C resistanceAccessing genetic variation: genotyping single nucleotide polymorphismsThe investigation and management of neonatal haemostasis and thrombosisBenign intracranial hypertension associated to blood coagulation derangementsThrombosis in multiple myelomaFactor V Leiden related Budd-Chiari syndromeThrombophilia: genetic polymorphisms and their association with retinal vascular occlusive diseaseProthrombotic phenotype of protein Z deficiencyAbsence of the blood-clotting regulator thrombomodulin causes embryonic lethality in mice before development of a functional cardiovascular systemEffects of protein S and factor Xa on peptide bond cleavages during inactivation of factor Va and factor VaR506Q by activated protein CThe European Hematology Association Roadmap for European Hematology Research: a consensus documentShort read (next-generation) sequencing: a tutorial with cardiomyopathy diagnostics as an exemplar.In vivo fluorescence imaging of large-vessel thrombosis in mice.Combined heterozygous plasminogen deficiency and factor V Leiden defect in the same kindred.Direct genetic analysis by matrix-assisted laser desorption/ionization mass spectrometryA system for specific, high-throughput genotyping by allele-specific primer extension on microarrays.
P2860
Q21093254-B1DDC924-C493-4060-BC6D-C55776889AA3Q21146747-6893AC8B-6AA9-470D-B649-346BA0415DEBQ22337119-1EAED68B-2DB4-4F05-BE8A-DE830F0F558FQ24201186-258FF435-CE64-4E17-A398-B41C3CC873A4Q24202395-792AFC80-E6B5-4BB7-883D-E7FD07D2742DQ24241821-E4E7ACA9-94A5-4A35-92C9-9196077CFE49Q24246284-078CC4BD-16CF-4DB1-8EA3-A378CFB8D452Q24321854-D8A4D836-6898-479D-A8D5-A8B6D2BACE06Q24564642-6FA5E987-BDF5-4AE6-AA3F-AE148AFFCBB1Q24604984-40F7200A-348B-424E-8C29-BD184F65C852Q24634989-08B6EF1E-8C6B-4041-BFA0-5A98778DEBA9Q24671543-94D3882F-EEDE-440C-9F0B-EB9068A0BE89Q24801115-8FEB1848-0207-48D2-8D09-17E07380E7E5Q25257578-2CF92AF0-4BCF-4094-9BB9-0E8D0EFB7CCDQ26774876-040662F9-88F7-42E6-BF95-71948706D691Q26830337-133783B4-5527-4DC9-9536-E1AA07316934Q26865139-13FF8754-5ECE-48FD-B652-71B3E9629060Q26999113-DD26877B-9C66-429D-A045-695F079CC182Q27021687-B4962EFD-033E-4F4E-AF22-DC339C75C390Q27734660-64F209C3-3A55-4701-9B3F-C53E6F0909F1Q28072544-AFE1FC0E-3DEB-4F1C-B878-0B164314A9D0Q28084640-046356A6-7038-4C7C-BE36-CB2046DB1D5BQ28143938-A94BB8C8-499D-40B0-80D2-73004A47C30DQ28187014-B85B3BA0-DAEE-42B3-BD20-E90FE5357DB2Q28188238-D20905F6-0AE6-4254-B47E-07816B650632Q28208864-9EB4FCE9-88D1-4AC0-8A28-493391DCC295Q28211888-13D7A240-832C-4C65-A5A3-6E47179283D5Q28213374-EA657AA0-3D45-419C-A313-0136725786D7Q28219961-CA5689C1-0DE8-430E-9269-60E16CABBCA4Q28345961-B9E16729-4E51-40E2-973B-C05045E0C428Q28367737-21CC4F33-F221-4154-99B7-0E53769CD557Q28509678-71DB633B-75F1-40F3-826C-247582972159Q28587880-51AEF8F6-FD64-450C-8E5A-789DC2FBE6A6Q28631087-A15F025A-31FC-418D-A697-85CA7F7080B6Q28830861-8720D8DE-2066-47FC-A1FC-42CC315D98E6Q30433575-B37D7B9E-4A02-4A79-BA88-6231CB73FA39Q30500329-3A22FC80-3ACD-4EEF-B9BE-40860A3F43BCQ30587606-B50421D9-CE07-40F5-98E5-A33CC489245BQ30639836-54E13A5B-B88D-4284-9D92-54D80ABB5B95Q30651566-2DC4107B-D9E2-4485-8DED-D958C8302AB6
P2860
Mutation in blood coagulation factor V associated with resistance to activated protein C.
description
1994 nî lūn-bûn
@nan
1994 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Mutation in blood coagulation factor V associated with resistance to activated protein C.
@ast
Mutation in blood coagulation factor V associated with resistance to activated protein C.
@en
Mutation in blood coagulation factor V associated with resistance to activated protein C.
@nl
type
label
Mutation in blood coagulation factor V associated with resistance to activated protein C.
@ast
Mutation in blood coagulation factor V associated with resistance to activated protein C.
@en
Mutation in blood coagulation factor V associated with resistance to activated protein C.
@nl
prefLabel
Mutation in blood coagulation factor V associated with resistance to activated protein C.
@ast
Mutation in blood coagulation factor V associated with resistance to activated protein C.
@en
Mutation in blood coagulation factor V associated with resistance to activated protein C.
@nl
P2093
P356
P1433
P1476
Mutation in blood coagulation factor V associated with resistance to activated protein C.
@en
P2093
Bertina RM
Koeleman BP
Reitsma PH
Rosendaal FR
de Ronde H
van der Velden PA
P2888
P356
10.1038/369064A0
P407
P577
1994-05-01T00:00:00Z
P5875
P6179
1024264501